| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,6 M € | +3.6% | 11,2 M € | -9.1% | 12,4 M € | -4.3% | 12,9 M € | -16.0% | 15,4 M € | +38.3% | 11,1 M € | -2.2% | 11,4 M € | -0.2% | 11,4 M € | -1.3% | 11,5 M € | +2.3% | 11,3 M € | +1.9% | 11,1 M € | +1.5% | 10,9 M € | -1.7% | 11,1 M € | +1.1% | 11,0 M € | +6.8% | 10,3 M € | -4.4% | 10,8 M € | -3.6% | 11,2 M € | +25.1% | 8,9 M € | |
| EBITDA | 2,7 M € | +13.3% | 2,4 M € | -18.2% | 2,9 M € | -27.2% | 4,0 M € | -4.4% | 4,2 M € | -5.8% | 4,4 M € | -11.0% | 5,0 M € | -3.2% | 5,2 M € | -6.5% | 5,5 M € | -0.2% | 5,5 M € | +0.5% | 5,5 M € | -0.8% | 5,5 M € | -7.3% | 6,0 M € | +3.0% | 5,8 M € | +7.7% | 5,4 M € | -7.8% | 5,8 M € | -5.6% | 6,2 M € | +24.5% | 5,0 M € | |
| Operating profit | 2,1 M € | +16.1% | 1,8 M € | -29.4% | 2,6 M € | -26.6% | 3,6 M € | -9.5% | 3,9 M € | -6.8% | 4,2 M € | -11.5% | 4,8 M € | -4.5% | 5,0 M € | -6.7% | 5,3 M € | -0.5% | 5,4 M € | +1.0% | 5,3 M € | -1.0% | 5,4 M € | -7.4% | 5,8 M € | +3.6% | 5,6 M € | +7.7% | 5,2 M € | -7.6% | 5,6 M € | -6.0% | 6,0 M € | +25.1% | 4,8 M € | |
| Profit/loss | 10,4 M € | -68.3% | 32,7 M € | +4312.7% | -776,9 k € | -103.2% | 24,4 M € | +928.5% | 2,4 M € | +1.9% | 2,3 M € | -87.9% | 19,2 M € | +178.6% | 6,9 M € | +9.9% | 6,3 M € | -46.2% | 11,6 M € | +480.4% | 2,0 M € | -58.5% | 4,8 M € | +135.8% | 2,0 M € | +15.7% | 1,8 M € | +582.4% | 259,7 k € | -92.3% | 3,4 M € | -17.1% | 4,1 M € | +23.0% | 3,3 M € | |
| Equity | 128,2 M € | +8.8% | 117,8 M € | +38.5% | 85,1 M € | -0.9% | 85,9 M € | +39.7% | 61,5 M € | +4.0% | 59,1 M € | +4.1% | 56,8 M € | -1.4% | 57,6 M € | +13.6% | 50,7 M € | +14.1% | 44,5 M € | +16.0% | 38,3 M € | +5.5% | 36,3 M € | -12.5% | 41,5 M € | +5.2% | 39,4 M € | +58.6% | 24,9 M € | +114.4% | 11,6 M € | +40.8% | 8,2 M € | +147.4% | 3,3 M € | |
| Total assets | 194,9 M € | +0.5% | 193,9 M € | +0.8% | 192,3 M € | -0.3% | 193,0 M € | -9.9% | 214,2 M € | +7.1% | 199,9 M € | -22.5% | 257,8 M € | +0.2% | 257,3 M € | -0.8% | 259,2 M € | +2.1% | 253,8 M € | +30.1% | 195,1 M € | -0.0% | 195,1 M € | +0.0% | 195,1 M € | -0.8% | 196,7 M € | -5.2% | 207,4 M € | +7.4% | 193,1 M € | +1924.8% | 9,5 M € | +115.1% | 4,4 M € | |
| Cash | 2,8 k € | +23.7% | 2,2 k € | +6.7% | 2,1 k € | +100.6% | 1,0 k € | +29.3% | 804,7 € | +36.3% | 590,6 € | +13.5% | 520,5 € | +13.8% | 457,3 € | -91.6% | 5,5 k € | -2.7% | 5,6 k € | -17.9% | 6,8 k € | +12.1% | 6,1 k € | -29.3% | 8,6 k € | -46.2% | 16,0 k € | +4.9% | 15,3 k € | +16.8% | 13,1 k € | +1.2% | 12,9 k € | +33.7% | 9,7 k € | |
| Debts | 66,7 M € | -12.4% | 76,1 M € | -29.0% | 107,2 M € | +0.1% | 107,1 M € | -29.8% | 152,7 M € | +8.5% | 140,7 M € | -30.0% | 201,0 M € | +0.7% | 199,6 M € | -4.2% | 208,4 M € | -0.4% | 209,3 M € | +33.6% | 156,7 M € | -1.2% | 158,7 M € | +3.3% | 153,5 M € | -2.3% | 157,1 M € | -13.9% | 182,5 M € | +0.6% | 181,5 M € | +14081.4% | 1,3 M € | +18.4% | 1,1 M € | |
| Staff | 51,5 | 50,2 | 48 | 47,4 | 49,6 | 43,5 | 42,1 | 43 | 42,9 | 40,4 | 38,7 | 40,4 | 38,1 | 38 | 40,1 | 41,1 | 38,8 | 34,5 | ||||||||||||||||||
Private limited company · Genk · incorporated on 15/09/1997 · 51,5 ETP
Private limited company profitable and well capitalised. Cash position rising (+23.7%).
Solid counterparty for a standard engagement.
KLINISCH LABO RIGO is a Private limited company incorporated in 1997. Its main activity is: Pre-primary education. Its registered office is in Genk. It employs on average 51,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette